[Drug therapy of acute cerebral ischemia. Clinical study].
D001921:Brain / Q000098:blood supply*; D003911:Dextrans / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D007511:Ischemia / Q000188:drug therapy*; D008012:Lidocaine / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D003911:Dextrans; D004088:Dihydroergotoxine; D004877:Ergoloid Mesylates; D008012:Lidocaine; D010208:Papaverine; D011241:Prednisone
La terapia medica dell'ischemia cerebrale acuta. Studio clinico